查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403425

到 2030 年皮下给药市场预测：按产品类型、适应症、配销通路和地区分類的全球分析

Subcutaneous Drug Delivery Devices Market Forecasts to 2030 - Global Analysis By Product, Type, Indication, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球皮下给药市场规模为 309 亿美元，预计在预测期内将以 11.3% 的复合年增长率增长，到 2030 年达到 654 亿美元。

医疗设备用于对患者给药皮下或皮下给药。这种药物传递方法优于其他方法，因为它可以将药物持续不断地释放到循环中，从而产生更少的副作用和更稳定的治疗效果。皮下药物输送系统由注射器、分配系统和插入皮下的药物容器组成。

根据美国多发性硬化症协会的数据，2017 年美国估计有 100 万成年人患有多发性硬化症。

慢性病增加

糖尿病、自体自体免疫疾病和心血管疾病等慢性病的盛行率不断上升，推动了对皮下给药装置的需求。这些设备为这些疾病的长期给药提供了有效的给药方式。因此，慢性病的快速增加预计将推动市场成长。

缺乏健康意识

在新兴和不发达国家，人们对药物、各种疾病和药物传输技术知之甚少。由于卫生保健设施不足，与慢性病相关的死亡人数不断增加。大多数农村人口仍未被发现和治疗。此外，由于药物和给药设备的成本高昂，皮下给药装置的使用在许多国家受到限制。这是阻碍市场扩张的重要因素。

对生物相似药和生技药品的需求不断增长

由于生物製药和生物相似药的快速普及，全球皮下给药装置市场的市场参与企业正享受着众多的成长机会。全球对皮下给药系统的需求是由对治疗慢性病的各种药物的不断增长的需求所推动的。生物製药和生物相似药的使用不断增加，通常需要皮下给药，这增加了对这些药物的专用输送设备的需求。

使用不当导致针刺伤

针刺伤和药物输送给药只是在没有正确资讯和说明的情况下不正确使用皮下给药装置时可能出现的两个问题。这使得患者更难以在多种药物传输选项之间进行选择。此外，与针头相关的血液感染疾病的风险可能最终成为一个主要障碍。

COVID-19 的影响：

皮下给药装置市场与整个医疗保健产业一样，受到了 COVID-19 爆发的重大影响。由于人们越来越关注家庭治疗、远距医疗保健和减少医院就诊，因此对自我给药设备的需求越来越大。此次疫情凸显了高效给药技术的重要性，并刺激了皮下给药市场的创新和投资。

预计在预测期内，穿戴式註射器细分市场将成为最大的细分市场

预计可穿戴注射器细分市场在预测期内将是最大的。这与针刺伤的增加以及注射使用引起的血源性疾病的风险增加有关。透过穿戴式註射器可以有效率地给药高黏度、大容量的生物製药。称为穿戴式註射器的数位药物给药工具非常方便，可以帮助患者在正确的时间给药正确的剂量。

神经系统疾病领域预计在预测期内复合年增长率最高。

神经系统疾病领域预计在预测期内复合年增长率最高。这些装置能够长期控制并稳定地释放药物。在癫痫和帕金森氏症等持续药物水平很重要的神经系统疾病中，这种控制释放可以帮助有效控制症状。这些设备的设计通常考虑到患者的舒适度，并且可以最大限度地减少治疗的侵入性。

比最大的地区

预计北美在预测期内将占据最大的市场占有率。这是由于各种慢性病的盛行率不断上升以及人们对药物和给药装置的需求不断增加。该市场的特点有很多因素，包括发达的医疗保健基础设施、该地区多个主要製造商、每个製造商不同的发展策略以及不断增加的医疗保健支出等，是其成长的重要原因。

复合年增长率最高的地区：

预计亚太地区在预测期内复合年增长率最高。这主要是由于该地区人民不健康的饮食习惯导致糖尿病人口迅速增加。可支配收入的增加、糖尿病管理意识的提高以及医疗保健支出的增加是近期推动市场成长的主要因素。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球皮下给药装置市场：副产品

  • 预充式註射器
  • 自动注射器
  • 穿戴式註射器
  • 笔式註射器
  • 无针注射器
  • 其他产品

第六章全球皮下给药装置市场：依类型

  • 一次性的
  • 可重复使用的

第七章全球皮下给药装置市场：依适应症分类

  • 神经系统疾病
  • 肿瘤疾病
  • 自体免疫疾病
  • 眼科疾病
  • 过敏及感染疾病
  • 荷尔蒙失调
  • 其他适应症

第八章全球皮下给药装置市场：依配销通路

  • 医院
  • 零售药房
  • 线上药房
  • 其他配销通路

第九章全球皮下给药装置市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Medtronic Plc
  • Gerresheimer AG
  • Elcam Medical Group
  • Insulet Corporation
  • Ypsomed AG
  • Becton, Dickinson and Company
  • PharmaJet
  • Unilife Corporation
  • In life Sciences
  • West Pharmaceutical Services, Inc.
  • Novo Nordisk
  • Eli Lilly
  • Merck
  • AstraZeneca
  • Amgen
  • Enable Injections
  • Consort Medical Plc
  • Wilhelm Haselmeier GmbH & Co. KG
Product Code: SMRC24650

According to Stratistics MRC, the Global Subcutaneous Drug Delivery Devices Market is accounted for $30.9 billion in 2023 and is expected to reach $65.4 billion by 2030 growing at a CAGR of 11.3% during the forecast period. Medical equipment called subcutaneous drug delivery devices is used to give patients medication subcutaneously, or under the skin. This method of drug delivery is preferred over others because it enables the drug's constant and continuous release into circulation, leading to less side effects and more consistent therapeutic advantages. Subcutaneous drug delivery systems consist of a syringe inserted under the skin, a distribution system, and a pharmaceutical container.

According to the National Multiple Sclerosis Society, an estimated 1.0 million adults were reported to be living with multiple sclerosis in the U.S. in 2017.

Market Dynamics:

Driver:

Rise in Chronic Diseases

Increasing prevalence of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions has driven the demand for subcutaneous drug delivery devices. These devices offer an effective way to administer medication for long-term management of these ailments. Therefore, the rapidly growing prevalence of chronic diseases is expected to drive the growth of the market.

Restraint:

Lack of health awareness

In emerging and undeveloped economies, there's a dearth of knowledge about pharmaceuticals, various ailments, and drug delivery technologies. Chronic illness-related fatalities rise as a result of inadequate healthcare facilities. Most rural residents continue to go undetected and untreated. Furthermore, the use of subcutaneous drug delivery devices is limited in a number of countries by the high cost of medications and drug administration equipment. This is a significant element that might impede market expansion.

Opportunity:

Growing demand for biosimilar and biologics

The market participants in the worldwide subcutaneous drug delivery devices market have a number of growth opportunities thanks to the quick rise in popularity of biologic and biosimilar medications. Global demand for subcutaneous drug delivery systems is being driven by the increasing need for different medications to treat chronic conditions. The growing use of biologics and biosimilars, which often require subcutaneous administration, has bolstered the demand for specialized delivery devices tailored for these medications.

Threat:

Improper use may give rise to needle stick injuries

Needlestick injuries and drug overdoses are only two of the issues that can arise from using subcutaneous medication delivery devices improperly without the right information and instruction. This can make it more difficult for the patients to choose between several drug delivery options. Furthermore, the dangers of blood-borne infections linked to injection needles might end up being a significant obstacle.

COVID-19 Impact:

The market for subcutaneous medication delivery devices has been significantly impacted by the COVID-19 epidemic, as has the whole healthcare sector. Self-administration devices are becoming more and more in demand as a result of the growing emphasis on home-based treatment, remote healthcare, and reducing hospital visits. The epidemic has brought attention to the significance of efficient medication delivery techniques, spurring innovation and investment in the subcutaneous drug delivery market.

The wearable injectors segment is expected to be the largest during the forecast period

The wearable injectors segment is expected to be the largest during the forecast period. This is linked to the increase in needle stick injuries as well as the increased risk of blood-borne illnesses from injection usage. The high-viscosity, high-volume biologic medications are administered with exceptional efficiency by the wearable injectors. Digital medicine administration tools called wearable injectors are convenient and assist patients in giving precise dosages at the appropriate times.

The neurological disorders segment is expected to have the highest CAGR during the forecast period

The neurological disorders segment is expected to have the highest CAGR during the forecast period. These devices can provide a controlled and steady release of medications over an extended period. For neurological disorders where consistent medication levels are crucial, such as in epilepsy or Parkinson's disease, this controlled release can help manage symptoms effectively. These devices are often designed for patient comfort, minimizing the invasiveness of treatments.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the increased prevalence of various chronic diseases resulted in the huge demand for drugs and drug delivery devices amongst the population. The market is growing due to a number of significant reasons, including the presence of improved healthcare infrastructure, the presence of multiple major manufacturers in the region and the different developmental strategies they have followed, and rising healthcare spending.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. This is majorly attributed to the rapidly growing diabetic population in the region owing to the unhealthy food habits of the people. The rising disposable income, growing awareness regarding the diabetes management, and rising healthcare expenditure are the major factors that will drive the growth of the market in the forthcoming future.

Key players in the market:

Some of the key players in Subcutaneous Drug Delivery Devices market include Medtronic Plc, Gerresheimer AG, Elcam Medical Group, Insulet Corporation, Ypsomed AG, Becton, Dickinson and Company, PharmaJet, Unilife Corporation, In life Sciences , West Pharmaceutical Services, Inc., Novo Nordisk, Eli Lilly, Merck, AstraZeneca, Amgen, Enable Injections, Consort Medical Plc and Wilhelm Haselmeier GmbH & Co. KG.

Key Developments:

In November 2023, The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's Zepbound™ (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.

In October 2023, Eli Lilly gives $20M upfront cash injection to Elektrofi in next-gen subcutaneous drug collab. Eli Lilly has tapped up drug delivery specialist Elektrofi to see whether the biotech's microparticle formulation technology could produce the next generation of subcutaneously administered therapies.

Products Covered:

  • Prefilled Syringes
  • Auto-Injectors
  • Wearable Injectors
  • Pen Injectors
  • Needle-Free Injectors
  • Other Products

Types Covered:

  • Disposable
  • Reusable

Indications Covered:

  • Neurological Disorders
  • Oncology Disorders
  • Auto-immune Disorders
  • Ophthalmic Disorders
  • Allergy & Infectious Disorders
  • Hormonal Disorders
  • Other Indications

Distribution Channels Covered:

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Subcutaneous Drug Delivery Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Prefilled Syringes
  • 5.3 Auto-Injectors
  • 5.4 Wearable Injectors
  • 5.5 Pen Injectors
  • 5.6 Needle-Free Injectors
  • 5.7 Other Products

6 Global Subcutaneous Drug Delivery Devices Market, By Type

  • 6.1 Introduction
  • 6.2 Disposable
  • 6.3 Reusable

7 Global Subcutaneous Drug Delivery Devices Market, By Indication

  • 7.1 Introduction
  • 7.2 Neurological Disorders
  • 7.3 Oncology Disorders
  • 7.4 Auto-immune Disorders
  • 7.5 Ophthalmic Disorders
  • 7.6 Allergy & Infectious Disorders
  • 7.7 Hormonal Disorders
  • 7.8 Other Indications

8 Global Subcutaneous Drug Delivery Devices Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Retail Pharmacies
  • 8.4 Online Pharmacies
  • 8.5 Other Distribution Channels

9 Global Subcutaneous Drug Delivery Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic Plc
  • 11.2 Gerresheimer AG
  • 11.3 Elcam Medical Group
  • 11.4 Insulet Corporation
  • 11.5 Ypsomed AG
  • 11.6 Becton, Dickinson and Company
  • 11.7 PharmaJet
  • 11.8 Unilife Corporation
  • 11.9 In life Sciences
  • 11.10 West Pharmaceutical Services, Inc.
  • 11.11 Novo Nordisk
  • 11.12 Eli Lilly
  • 11.13 Merck
  • 11.14 AstraZeneca
  • 11.15 Amgen
  • 11.16 Enable Injections
  • 11.17 Consort Medical Plc
  • 11.18 Wilhelm Haselmeier GmbH & Co. KG

List of Tables

  • Table 1 Global Subcutaneous Drug Delivery Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 4 Global Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 5 Global Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 6 Global Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 7 Global Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 8 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 10 Global Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 11 Global Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 12 Global Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 13 Global Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 14 Global Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 15 Global Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 16 Global Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 17 Global Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 18 Global Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 19 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 20 Global Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 21 Global Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 22 Global Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 23 Global Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 24 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 25 North America Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 27 North America Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 28 North America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 29 North America Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 30 North America Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 31 North America Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 32 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 33 North America Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 34 North America Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 35 North America Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 36 North America Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 37 North America Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 38 North America Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 39 North America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 40 North America Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 41 North America Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 42 North America Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 43 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 44 North America Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 45 North America Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 46 North America Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 47 North America Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 48 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 49 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 51 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 52 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 53 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 54 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 55 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 56 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 57 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 58 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 59 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 60 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 61 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 62 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 63 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 64 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 65 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 66 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 67 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 68 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 69 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 70 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 71 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 72 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 73 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 76 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 77 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 78 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 79 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 80 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 81 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 82 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 83 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 84 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 85 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 86 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 87 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 88 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 89 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 90 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 91 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 92 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 93 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 94 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 95 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 96 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 97 South America Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 99 South America Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 100 South America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 101 South America Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 102 South America Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 103 South America Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 104 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 105 South America Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 106 South America Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 107 South America Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 108 South America Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 109 South America Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 110 South America Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 111 South America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 112 South America Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 113 South America Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 114 South America Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 115 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 116 South America Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 117 South America Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 118 South America Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 119 South America Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 120 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 121 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 123 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2021-2030) ($MN)
  • Table 124 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2021-2030) ($MN)
  • Table 125 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2021-2030) ($MN)
  • Table 126 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2021-2030) ($MN)
  • Table 127 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2021-2030) ($MN)
  • Table 128 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 129 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Type (2021-2030) ($MN)
  • Table 130 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 131 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 132 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2021-2030) ($MN)
  • Table 133 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 134 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2021-2030) ($MN)
  • Table 135 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2021-2030) ($MN)
  • Table 136 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2021-2030) ($MN)
  • Table 137 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2021-2030) ($MN)
  • Table 138 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2021-2030) ($MN)
  • Table 139 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 140 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 141 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 142 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 143 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 144 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2021-2030) ($MN)